A Cross-sectional Observational Study to Investigate Daily Symptom Variability, Effects of Symptom on Morning Activities and Therapeutic Expectations of Patients and Physicians in Chronic Obstructive Pulmonary Disease - SUNRISE Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Obstructive Pulmonary Disease
- Sponsor
- AstraZeneca
- Enrollment
- 515
- Locations
- 1
- Primary Endpoint
- To evaluate daily symptom variability in Chronic Obstructive Pulmonary Disease (COPD) patients
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
The primary objective of this non-interventional study is to evaluate daily symptom variability in COPD patients. The secondary objectives are; to evaluate effects of COPD symptoms on the morning activities of patients, to determine therapeutic expectations of patients and physicians in COPD, to determine which and how frequent non-drug approaches are recommended in order to prevent COPD exacerbations, to define COPD patient profiles about the below-mentioned issues: Demographic characteristics, Disease characteristics, Concomitant diseases and implemented drug treatments. All patients, who apply to the study physicians and fulfill all patient selection criteria during patient enrolment period, will be included. Patients, who provide all of the following measures will be included in the study: To apply to a physician for outpatient treatment for any reason, Age over 45 years, being diagnosed with COPD, being a smoker or used to be a smoker once (> 10 package years), to give consent for the use of their medical data. The patients that exhibit the following exclusion criteria will be excluded from the study: COPD exacerbations still on-going or experienced in the last 3 months (Exacerbation is defined as worsening of COPD symptoms leading to antibiotic and/or short-term oral steroid treatment and/or hospitalization or admission to the emergency unit.); Presence of lung cancer or an important respiratory disease such as bronchiectasis, pulmonary fibrosis, interstitial pulmonary disease, tuberculosis, sarcoidosis; Participation in an interventional clinical trial at present and Enrollment in this study once. In this study, patients will be recorded at their visit to the physician and there will be no follow-up thereafter.
Investigators
Eligibility Criteria
Inclusion Criteria
- •To apply to a physician for outpatient treatment for any reason; being diagnosed with COPD
- •being a smoker or used to be a smoker once (\> 10 package years)
- •to give consent for the use of their medical data
Exclusion Criteria
- •COPD exacerbations still on-going or experienced in the last 3 months
- •Presence of lung cancer or an important respiratory disease such as bronchiectasis, pulmonary fibrosis, interstitial pulmonary disease, tuberculosis, sarcoidosis
- •Participation in an interventional clinical trial at present and Enrollment in this study once
Outcomes
Primary Outcomes
To evaluate daily symptom variability in Chronic Obstructive Pulmonary Disease (COPD) patients
Time Frame: April - Dec 2010
Secondary Outcomes
- To evaluate effects of COPD symptoms on the morning activities of patients; To determine therapeutic expectations of patients and physicians in COPD(April - Dec 2010)
- To define COPD patient profiles about the below-mentioned issues: Demographic characteristics; Disease characteristics; Concomitant diseases; Implemented drug treatments(April - Dec 2010)
- To determine which and how frequent non-drug approaches are recommended in order to prevent COPD exacerbations(April - Dec 2010)